COPD Co-morbidites, CVD and metabolic diseases

COPD_CVDMETABOCOMORB

No definition available.

Endpoint definition

FinnGen phenotype data

356077 individuals

diagram downward connector

Apply sex-specific rule None

356077

diagram downward connector

Check conditions None

356077

diagram downward connector

Filter registries None

0

diagram downward connector

Check pre-conditions, main-only, mode, ICD version None

0

diagram downward connector

Check minimum number of events None

0

diagram downward connector
COPD_CVDMETABOCOMORB

Extra metadata

First used in FinnGen datafreeze DF2

Similar endpoints

Summary Statistics

Key figures

All Female Male
Number of individuals 139383 61429 77954
Unadjusted prevalence (%) 39.18 30.96 49.53
Mean age at first event (years) 57.34 55.94 58.44

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.05 4.48 [4.21, 4.77] <1e-100 26994
15 years 0.02 3.21 [3.00, 3.44] <1e-100 11811
5 years 0.00 4.52 [4.20, 4.87] <1e-100 5627
1 year 0.00 21.04 [18.45, 24.00] <1e-100 4723

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: COPD_CVDMETABOCOMORB – COPD Co-morbidites, CVD and metabolic diseases
GWS hits:

Survival analyses between endpoints

Plot

before COPD Co-morbidites, CVD and metabolic diseases
after COPD Co-morbidites, CVD and metabolic diseases

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after COPD Co-morbidites, CVD and metabolic diseases